Makoto Asahina Selected Research

Alacrima

1/2021	Reversibility of motor dysfunction in the rat model of NGLY1 deficiency.
1/2020	Ngly1 -/- rats develop neurodegenerative phenotypes and pathological abnormalities in their peripheral and central nervous systems.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Makoto Asahina Research Topics

Disease

4	NGLY1 deficiency 01/2021 - 01/2020
4	Hypercholesterolemia 01/2020 - 10/2005
2	Intellectual Disability (Idiocy) 01/2021 - 01/2020
2	Alacrima 01/2021 - 01/2020
2	Atherosclerosis 01/2017 - 02/2012
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2021
1	Movement Disorders (Movement Disorder) 01/2020
1	Aortic Dissection 01/2017
1	Thrombosis (Thrombus) 01/2017
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2017
1	Dyslipidemias (Dyslipidemia) 01/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015
1	Hyperlipidemias (Hyperlipidemia) 02/2012
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 02/2012

Drug/Important Bio-Agent (IBA)

3	Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidaseIBA 01/2021 - 01/2020
2	Dietary CholesterolIBA 01/2020 - 01/2014
2	CholesterolIBA 01/2017 - 10/2005
1	N-acetylglucosaminylasparagineIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Apolipoproteins B (ApoB)IBA 01/2015
1	ApolipoproteinsIBA 01/2015
1	Triglycerides (Triacylglycerol)IBA 01/2014
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 02/2012
1	LigandsIBA 02/2012
1	LDL Receptors (LDL Receptor)IBA 02/2012
1	LipidsIBA 02/2012